These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27567133)

  • 1. Usefulness of 14-Day Holter for Detection of Nonsustained Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    Weissler-Snir A; Chan RH; Adler A; Care M; Chauhan V; Gollob MH; Ziv-Baran T; Fourey D; Hindieh W; Rakowski H; Spears DA
    Am J Cardiol; 2016 Oct; 118(8):1258-1263. PubMed ID: 27567133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
    Wang W; Lian Z; Rowin EJ; Maron BJ; Maron MS; Link MS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Device-Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy.
    Viswanathan K; Suszko AM; DAS M; Jackson N; Gollob M; Cameron D; Spears D; Woo A; Rakowski H; Khurana M; Chauhan VS
    Pacing Clin Electrophysiol; 2016 Jul; 39(7):642-51. PubMed ID: 27027856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.
    Francia P; Santini D; Musumeci B; Semprini L; Adduci C; Pagannone E; Proietti G; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1180-7. PubMed ID: 25066044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
    J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM
    J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal left ventricular strain in hypertrophic cardiomyopathy: correlation with nonsustained ventricular tachycardia.
    Correia E; Rodrigues B; Santos LF; Moreira D; Gama P; Cabral C; Santos O
    Echocardiography; 2011 Aug; 28(7):709-14. PubMed ID: 21564281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.
    Monserrat L; Elliott PM; Gimeno JR; Sharma S; Penas-Lado M; McKenna WJ
    J Am Coll Cardiol; 2003 Sep; 42(5):873-9. PubMed ID: 12957435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy.
    Liu L; Liu S; Shen L; Tu B; Hu Z; Hu F; Zheng L; Ding L; Fan X; Yao Y
    Clin Cardiol; 2020 Oct; 43(10):1150-1159. PubMed ID: 32810305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
    Cecchi F; Olivotto I; Montereggi A; Squillatini G; Dolara A; Maron BJ
    Heart; 1998 Apr; 79(4):331-6. PubMed ID: 9616338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstructive sleep apnea is associated with nonsustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
    Wang S; Cui H; Song C; Zhu C; Wu R; Meng L; Yu Q; Huang X; Wang S
    Heart Rhythm; 2019 May; 16(5):694-701. PubMed ID: 30576881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the corrected QT before the onset of nonsustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Baranowski R; Chojnowska L; Michalak E; Orłowska-Baranowska E
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):387-9. PubMed ID: 12687851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia.
    Dimitrow PP; Klimeczek P; Vliegenthart R; Pasowicz M; Oudkerk M; Podolec P; Tracz W; Dubiel JS
    Int J Cardiovasc Imaging; 2008 Jan; 24(1):77-83; discussion 85-7. PubMed ID: 17624806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular mechanical dispersion is associated with nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.
    Jalanko M; Tarkiainen M; Sipola P; Jääskeläinen P; Lauerma K; Laine M; Nieminen MS; Laakso M; Heliö T; Kuusisto J
    Ann Med; 2016 Sep; 48(6):417-427. PubMed ID: 27249556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non sustained ventricular tachycardia in hypertrophic cardiomyopathy and new ultrasonic derived parameters.
    Di Salvo G; Pacileo G; Limongelli G; Baldini L; Rea A; Verrengia M; D'Andrea A; Russo MG; Calabrò R
    J Am Soc Echocardiogr; 2010 Jun; 23(6):581-90. PubMed ID: 20362415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
    Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification for serious arrhythmic events using nonsustained ventricular tachycardia and heart rate turbulence detected by 24-hour holter electrocardiograms in patients with left ventricular dysfunction.
    Miwa Y; Yoshino H; Hoshida K; Miyakoshi M; Tsukada T; Yusu S; Ikeda T
    Ann Noninvasive Electrocardiol; 2012 Jul; 17(3):260-7. PubMed ID: 22816545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment?
    Zecchin M; Di Lenarda A; Gregori D; Merlo M; Pivetta A; Vitrella G; Sabbadini G; Mestroni L; Sinagra G
    Pacing Clin Electrophysiol; 2008 Mar; 31(3):290-9. PubMed ID: 18307623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.